These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 10076170)

  • 1. Vasomotor flushes in menopausal women.
    Bachmann GA
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S312-6. PubMed ID: 10076170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen cotherapy in menopause: evolving benefits and challenges.
    Bachmann GA
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S308-11. PubMed ID: 10076169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of androgens in surgical menopause.
    Gelfand MM
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S325-7. PubMed ID: 10076173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH
    Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens and estrogens in relation to hot flushes during the menopausal transition.
    Øverlie I; Moen MH; Holte A; Finset A
    Maturitas; 2002 Jan; 41(1):69-77. PubMed ID: 11809345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal hot flushes and night sweats: where are we now?
    Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
    Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis.
    Mohammady M; Janani L; Jahanfar S; Mousavi MS
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():295-302. PubMed ID: 30056356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
    Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical activity alone and in combination with hormone replacement therapy on vasomotor symptoms in postmenopausal women.
    Li S; Holm K
    West J Nurs Res; 2003 Apr; 25(3):274-88; discussion 289-93. PubMed ID: 12705112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Hot Flushes in Menopausal Women: A Review.
    Mallhi TH; Khan YH; Khan AH; Mahmood Q; Khalid SH; Saleem M
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):460-465. PubMed ID: 29848424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.
    Alexander JL; Burger H; Dennerstein L; Woods NF; Davis SR; Kotz K; Van Winkle J; Richardson G; Ratka A; Kessel B
    Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S115-37. PubMed ID: 18039061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical data.
    Constantine GD; Archer DF; Pollycove R; Jiang W; Altomare C; Pinkerton JV
    Menopause; 2016 Sep; 23(9):957-64. PubMed ID: 27404027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.
    Gupta P; Sturdee DW; Palin SL; Majumder K; Fear R; Marshall T; Paterson I
    Climacteric; 2006 Feb; 9(1):49-58. PubMed ID: 16428125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.
    Stovall DW; Pinkerton JV
    Curr Opin Investig Drugs; 2009 Apr; 10(4):365-71. PubMed ID: 19337958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen--no matter how delivered--relieves postmenopausal vasomotor symptoms.
    Bachmann G
    Menopause; 2003; 10(6):494-6. PubMed ID: 14627856
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone alternative doesn't worsen vasomotor symptoms or impact urinary incontinence in post-menopausal women.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Mar; 15(5):7-9. PubMed ID: 15025087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.